{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:25:41Z","timestamp":1791897941184,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201990"],"award-info":[{"award-number":["82201990"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071834"],"award-info":[{"award-number":["82071834"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010018","name":"Doctoral Start-up Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2020-BS-191"],"award-info":[{"award-number":["2020-BS-191"]}],"id":[{"id":"10.13039\/501100010018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010086","name":"Foundation of Liaoning Province Education Administration","doi-asserted-by":"publisher","award":["LZ2020051"],"award-info":[{"award-number":["LZ2020051"]}],"id":[{"id":"10.13039\/501100010086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009965","name":"Dalian Science and Technology Bureau","doi-asserted-by":"publisher","award":["2021JJ13SN48"],"award-info":[{"award-number":["2021JJ13SN48"]}],"id":[{"id":"10.13039\/501100009965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011002","name":"National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund","doi-asserted-by":"publisher","award":["82271839"],"award-info":[{"award-number":["82271839"]}],"id":[{"id":"10.13039\/501100011002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dalian Key Laboratory of Human Micro-organism Homeostasis and Immunological Mechanism Research of Diseases."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Our and other researchers\u2019 previous studies found that myeloid-derived suppressor cells (MDSCs) were increased, and these MDSCs, supposed to play immunosuppressive roles, showed significant pro-inflammatory effects in Sj\u00f6gren\u2019s syndrome (SS). However, the key factors and potential mechanisms leading MDSCs to be inflammatory remain unclear. In this study, we found that MDSCs from SS patients were positively correlated with the percentages of Th17 cells, disease activity and serum autoantibodies, and showed higher levels of Fc gamma receptor (Fc\u03b3R) IIIA and glycolysis. Most importantly, SS MDSCs or heat-aggregated IgG (HAIG)-treated MDSCs down-regulated Th1\/Th2 ratio and up-regulated Th17\/Treg ratio, which could be obviously rescued by IgG monomer or glycolysis inhibitor 2-DG. As well, the levels of Fc\u03b3RIV and glycolysis in MDSCs and the ratio of Th17\/Treg were increased, and the ratio of Th1\/Th2 was decreased in SS-like NOD mice. Our study indicated that MDSCs showed pro-inflammatory phenotypes by disturbing CD4<jats:sup>+<\/jats:sup> T-cell balances in SS. The pro-inflammatory effects of MDSCs might be directly linked to the enhanced glycolysis mediated by Fc\u03b3RIIIA activation.<\/jats:p>","DOI":"10.1038\/s41419-023-05631-4","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T11:02:50Z","timestamp":1675681370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Fc\u03b3RIIIA activation-mediated up-regulation of glycolysis alters MDSCs modulation in CD4+ T cell subsets of Sj\u00f6gren syndrome"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5224-4416","authenticated-orcid":false,"given":"Jingjing","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8338-2558","authenticated-orcid":false,"given":"Xinyang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziran","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minli","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0205-6732","authenticated-orcid":false,"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,6]]},"reference":[{"key":"5631_CR1","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.autrev.2018.05.005","volume":"17","author":"K Psianou","year":"2018","unstructured":"Psianou K, Panagoulias I, Papanastasiou AD, de Lastic AL, Rodi M, Spantidea PI, et al. Clinical and immunological parameters of Sj\u00f6gren\u2019s syndrome. Autoimmun Rev. 2018;17:1053\u201364.","journal-title":"Autoimmun Rev"},{"key":"5631_CR2","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","volume":"2","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, et al. Sj\u00f6gren syndrome. Nat Rev Dis Prim. 2016;2:16047.","journal-title":"Nat Rev Dis Prim"},{"key":"5631_CR3","first-page":"191","volume":"47","author":"MN Manoussakis","year":"2001","unstructured":"Manoussakis MN, Moutsopoulos HM. Sj\u00f6gren\u2019s syndrome: current concepts. Adv Intern Med. 2001;47:191\u2013217.","journal-title":"Adv Intern Med"},{"key":"5631_CR4","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/1756-185X.13464","volume":"22","author":"M Tsukamoto","year":"2019","unstructured":"Tsukamoto M, Suzuki K, Takeuchi T. Ten-year observation of patients with primary Sj\u00f6gren\u2019s syndrome: Initial presenting characteristics and the associated outcomes. Int J Rheum Dis. 2019;22:929\u201333.","journal-title":"Int J Rheum Dis"},{"key":"5631_CR5","doi-asserted-by":"publisher","first-page":"721453","DOI":"10.3389\/fimmu.2021.721453","volume":"12","author":"SH Hwang","year":"2021","unstructured":"Hwang SH, Woo JS, Moon J, Yang S, Park JS, Lee J, et al. IL-17 and CCR9(+) \u03b14\u03b27(-) Th17 cells promote salivary gland inflammation, dysfunction, and cell death in Sj\u00f6gren\u2019s syndrome. Front Immunol. 2021;12:721453.","journal-title":"Front Immunol"},{"key":"5631_CR6","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nrrheum.2013.110","volume":"9","author":"G Nocturne","year":"2013","unstructured":"Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sj\u00f6gren\u2019s syndrome. Nat Rev Rheumatol. 2013;9:544\u201356.","journal-title":"Nat Rev Rheumatol"},{"key":"5631_CR7","first-page":"1131","volume":"20","author":"J Qi","year":"2019","unstructured":"Qi J, Li D, Shi G, Zhang X, Pan Y, Dou H, et al. Interleukin\u201112 exacerbates Sj\u00f6gren\u2019s syndrome through induction of myeloid\u2011derived suppressor cells. Mol Med Rep. 2019;20:1131\u20138.","journal-title":"Mol Med Rep."},{"key":"5631_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04487-w","volume":"13","author":"Y Sun","year":"2022","unstructured":"Sun Y, Han X, Shang C, Wang Y, Xu B, Jiang S, et al. The downregulation of type I IFN signaling in G-MDSCs under tumor conditions promotes their development towards an immunosuppressive phenotype. Cell Death Dis. 2022;13:36.","journal-title":"Cell Death Dis"},{"key":"5631_CR9","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1002\/art.39767","volume":"68","author":"MJ Park","year":"2016","unstructured":"Park MJ, Lee SH, Kim EK, Lee EJ, Park SH, Kwok SK, et al. Myeloid-derived suppressor cells induce the expansion of regulatory B cells and ameliorate autoimmunity in the sanroque mouse model of systemic lupus erythematosus. Arthritis Rheumatol. 2016;68:2717\u201327.","journal-title":"Arthritis Rheumatol"},{"key":"5631_CR10","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.4049\/jimmunol.1203535","volume":"191","author":"W Fujii","year":"2013","unstructured":"Fujii W, Ashihara E, Hirai H, Nagahara H, Kajitani N, Fujioka K, et al. Myeloid-derived suppressor cells play crucial roles in the regulation of mouse collagen-induced arthritis. J Immunol. 2013;191:1073\u201381.","journal-title":"J Immunol"},{"key":"5631_CR11","doi-asserted-by":"publisher","first-page":"165554","DOI":"10.1016\/j.bbadis.2019.165554","volume":"1866","author":"G Dong","year":"2020","unstructured":"Dong G, Yang Y, Li X, Yao X, Zhu Y, Zhang H, et al. Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165554.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"5631_CR12","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1093\/rheumatology\/keaa625","volume":"60","author":"S Chen","year":"2021","unstructured":"Chen S, Guo C, Wang R, Feng Z, Liu Z, Wu L, et al. Monocytic MDSCs skew Th17 cells toward a pro-osteoclastogenic phenotype and potentiate bone erosion in rheumatoid arthritis. Rheumatology. 2021;60:2409\u201320.","journal-title":"Rheumatology"},{"key":"5631_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.molimm.2018.07.016","volume":"101","author":"J Qi","year":"2018","unstructured":"Qi J, Li D, Shi G, Zhang X, Pan Y, Dou H, et al. Myeloid-derived suppressor cells exacerbate Sj\u00f6gren\u2019s syndrome by inhibiting Th2 immune responses. Mol Immunol. 2018;101:251\u20138.","journal-title":"Mol Immunol."},{"key":"5631_CR14","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.4049\/jimmunol.1801051","volume":"202","author":"J Tian","year":"2019","unstructured":"Tian J, Rui K, Hong Y, Wang X, Xiao F, Lin X, et al. Increased GITRL impairs the function of myeloid-derived suppressor cells and exacerbates primary Sj\u00f6gren syndrome. J Immunol. 2019;202:1693\u2013703.","journal-title":"J Immunol"},{"key":"5631_CR15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/s41423-020-00587-3","volume":"18","author":"K Rui","year":"2021","unstructured":"Rui K, Hong Y, Zhu Q, Shi X, Xiao F, Fu H, et al. Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sj\u00f6gren\u2019s syndrome by modulating the function of myeloid-derived suppressor cells. Cell Mol Immunol. 2021;18:440\u201351.","journal-title":"Cell Mol Immunol."},{"key":"5631_CR16","doi-asserted-by":"publisher","first-page":"604607","DOI":"10.3389\/fimmu.2020.604607","volume":"11","author":"J Tian","year":"2020","unstructured":"Tian J, Hong Y, Zhu Q, Zhou H, Zhang Y, Shen Z, et al. Mesenchymal stem cell enhances the function of MDSCs in experimental Sj\u00f6gren syndrome. Front Immunol. 2020;11:604607.","journal-title":"Front Immunol"},{"key":"5631_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s13287-020-01837-x","volume":"11","author":"J Qi","year":"2020","unstructured":"Qi J, Tang X, Li W, Chen W, Yao G, Sun L. Mesenchymal stem cells inhibited the differentiation of MDSCs via COX2\/PGE2 in experimental sialadenitis. Stem Cell Res Ther. 2020;11:325.","journal-title":"Stem Cell Res Ther"},{"key":"5631_CR18","doi-asserted-by":"publisher","first-page":"114360","DOI":"10.1016\/j.bcp.2020.114360","volume":"183","author":"Y Wu","year":"2021","unstructured":"Wu Y, Pan W, Hu X, Zhang A, Wei W. The prospects for targeting FcR as a novel therapeutic strategy in rheumatoid arthritis. Biochem Pharmacol. 2021;183:114360.","journal-title":"Biochem Pharmacol."},{"key":"5631_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2206","volume":"8","author":"F Nimmerjahn","year":"2008","unstructured":"Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol. 2008;8:34\u201347.","journal-title":"Nat Rev Immunol."},{"key":"5631_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40425-015-0097-6","volume":"3","author":"J Li","year":"2015","unstructured":"Li J, Srivastava RM, Ettyreddy A, Ferris RL. Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patients. J Immunother Cancer. 2015;3:54.","journal-title":"J Immunother Cancer"},{"key":"5631_CR21","doi-asserted-by":"publisher","first-page":"842","DOI":"10.7150\/thno.66575","volume":"12","author":"L Wu","year":"2022","unstructured":"Wu L, Xu Y, Zhao H, Zhou Y, Chen Y, Yang S, et al. Fc\u03b3RIIB potentiates differentiation of myeloid-derived suppressor cells to mediate tumor immunoescape. Theranostics. 2022;12:842\u201358.","journal-title":"Theranostics"},{"key":"5631_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2018.04.022","volume":"28","author":"W Li","year":"2018","unstructured":"Li W, Tanikawa T, Kryczek I, Xia H, Li G, Wu K, et al. Aerobic glycolysis controls myeloid-derived suppressor cells and tumor immunity via a specific CEBPB isoform in triple-negative breast cancer. Cell Metab. 2018;28:87\u2013103.e6.","journal-title":"Cell Metab"},{"key":"5631_CR23","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1042\/CS20200799","volume":"134","author":"B Pang","year":"2020","unstructured":"Pang B, Zhen Y, Hu C, Ma Z, Lin S, Yi H. Myeloid-derived suppressor cells shift Th17\/Treg ratio and promote systemic lupus erythematosus progression through arginase-1\/miR-322-5p\/TGF-\u03b2 pathway. Clin Sci. 2020;134:2209\u201322.","journal-title":"Clin Sci"},{"key":"5631_CR24","doi-asserted-by":"publisher","first-page":"8253","DOI":"10.7150\/thno.37351","volume":"9","author":"G Yao","year":"2019","unstructured":"Yao G, Qi J, Liang J, Shi B, Chen W, Li W, et al. Mesenchymal stem cell transplantation alleviates experimental Sj\u00f6gren\u2019s syndrome through IFN-\u03b2\/IL-27 signaling axis. Theranostics. 2019;9:8253\u201365.","journal-title":"Theranostics"},{"key":"5631_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbadis.2018.10.007","volume":"1865","author":"G Shi","year":"2019","unstructured":"Shi G, Li D, Li X, Ren J, Xu J, Ding L, et al. mTOR inhibitor INK128 attenuates systemic lupus erythematosus by regulating inflammation-induced CD11b (+) Gr1(+) cells. Biochim Biophys Acta Mol Basis Dis. 2019;1865:1\u201313.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"5631_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ebiom.2019.08.025","volume":"47","author":"L Fultang","year":"2019","unstructured":"Fultang L, Panetti S, Ng M, Collins P, Graef S, Rizkalla N, et al. MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers. EBioMedicine. 2019;47:235\u201346.","journal-title":"EBioMedicine"},{"key":"5631_CR27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","volume":"54","author":"S Hegde","year":"2021","unstructured":"Hegde S, Leader AM, Merad M. MDSC: markers, development, states, and unaddressed complexity. Immunity. 2021;54:875\u201384.","journal-title":"Immunity"},{"key":"5631_CR28","doi-asserted-by":"publisher","first-page":"103016","DOI":"10.1016\/j.autrev.2021.103016","volume":"21","author":"E Chalayer","year":"2022","unstructured":"Chalayer E, Gramont B, Zekre F, Goguyer-Deschaumes R, Waeckel L, Grange L, et al. Fc receptors gone wrong: a comprehensive review of their roles in autoimmune and inflammatory diseases. Autoimmun Rev. 2022;21:103016.","journal-title":"Autoimmun Rev"},{"key":"5631_CR29","doi-asserted-by":"publisher","first-page":"102366","DOI":"10.1016\/j.autrev.2019.102366","volume":"18","author":"AW Zuercher","year":"2019","unstructured":"Zuercher AW, Spirig R, Baz Morelli A, Rowe T, K\u00e4sermann F. Next-generation Fc receptor-targeting biologics for autoimmune diseases. Autoimmun Rev. 2019;18:102366.","journal-title":"Autoimmun Rev"},{"key":"5631_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/imr.13109","volume":"309","author":"JC Gonzalez","year":"2022","unstructured":"Gonzalez JC, Chakraborty S, Thulin NK, Wang TT. Heterogeneity in IgG-CD16 signaling in infectious disease outcomes. Immunol Rev. 2022;309:64\u201374.","journal-title":"Immunol Rev."},{"key":"5631_CR31","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.3390\/cells10102700","volume":"10","author":"F Hofer","year":"2021","unstructured":"Hofer F, Di Sario G, Musiu C, Sartoris S, De Sanctis F, Ugel S. A complex metabolic network confers immunosuppressive functions to myeloid-derived suppressor cells (MDSCs) within the tumour microenvironment. Cells. 2021;10:2700.","journal-title":"Cells"},{"key":"5631_CR32","doi-asserted-by":"publisher","first-page":"109883","DOI":"10.1016\/j.celrep.2021.109883","volume":"37","author":"H Mohammadpour","year":"2021","unstructured":"Mohammadpour H, MacDonald CR, McCarthy PL, Abrams SI, Repasky EA. \u03b22-adrenergic receptor signaling regulates metabolic pathways critical to myeloid-derived suppressor cell function within the TME. Cell Rep. 2021;37:109883.","journal-title":"Cell Rep."},{"key":"5631_CR33","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.tibs.2016.05.013","volume":"41","author":"AE Boukouris","year":"2016","unstructured":"Boukouris AE, Zervopoulos SD, Michelakis ED. Metabolic enzymes moonlighting in the nucleus: metabolic regulation of gene transcription. Trends Biochem Sci. 2016;41:712\u201330.","journal-title":"Trends Biochem Sci."},{"key":"5631_CR34","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.molcel.2020.04.002","volume":"78","author":"Z Zas\u0142ona","year":"2020","unstructured":"Zas\u0142ona Z, O\u2019Neill L. Cytokine-like roles for metabolites in immunity. Mol Cell. 2020;78:814\u201323.","journal-title":"Mol Cell"},{"key":"5631_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2020.09.014","volume":"54","author":"C Diskin","year":"2021","unstructured":"Diskin C, Ryan T, O\u2019Neill L. Modification of proteins by metabolites in immunity. Immunity. 2021;54:19\u201331.","journal-title":"Immunity"},{"key":"5631_CR36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.tem.2018.03.016","volume":"29","author":"N Weisshaar","year":"2018","unstructured":"Weisshaar N, Madi A, Cui G. Early TCR signaling sweetens effector function through PDHK1. Trends Endocrinol Metab: TEM. 2018;29:595\u20137.","journal-title":"Trends Endocrinol Metab: TEM"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05631-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05631-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05631-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T11:06:11Z","timestamp":1675681571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05631-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,6]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["5631"],"URL":"https:\/\/doi.org\/10.1038\/s41419-023-05631-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,6]]},"assertion":[{"value":"29 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}